Your browser doesn't support javascript.
loading
Frameshift mutations, neoantigens and tumor-specific CD8(+) T cells in microsatellite unstable colorectal cancers.
Maby, Pauline; Galon, Jérôme; Latouche, Jean-Baptiste.
Afiliação
  • Maby P; Inserm U1079, Institute for Research and Innovation in Biomedecine (IRIB), Rouen, France; Inserm U872, Laboratory of Integrative Cancer Immunology, Paris, France; Université Paris Descartes, Paris, France; Cordeliers Research Center, Université Pierre et Marie Curie, Paris 6, Paris, France.
  • Galon J; Inserm U872, Laboratory of Integrative Cancer Immunology, Paris, France; Université Paris Descartes, Paris, France; Cordeliers Research Center, Université Pierre et Marie Curie, Paris 6, Paris, France.
  • Latouche JB; Inserm U1079, Institute for Research and Innovation in Biomedecine (IRIB), Rouen, France; Department of Genetics, Rouen University Hospital, Rouen, France.
Oncoimmunology ; 5(5): e1115943, 2016 May.
Article em En | MEDLINE | ID: mdl-27467916
Microsatellite unstable colorectal cancers (CRC) express frameshift mutation-derived tumor-specific neoantigens. We recently showed that: (i) frameshift mutations were correlated with tumor-infiltrating CD8(+) T cell density, (ii) neoantigen-specific cytotoxic T cells could be obtained in patients whose tumors harbored these mutations, underlining the interest of developing personalized immunotherapy strategies in these cancers.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2016 Tipo de documento: Article